Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review)
Shengnan Ren, Zhanyi Zhang, Mengyuan Li, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 6
Open Access | Times Cited: 12

Showing 12 citing articles:

Melanoma-associated antigen A4: A cancer/testis antigen as a target for adoptive T-cell receptor T-cell therapy
Gabrielle J. Knafler, Alan L. Ho, Kathleen Moore, et al.
Cancer Treatment Reviews (2025), pp. 102891-102891
Closed Access
Antibodies Against Melanoma Antigens – Clinical and Therapeutical Markers
Monica Neagu
(2025), pp. 1-22
Closed Access
Machine Learning for Early Discrimination Between Lung Cancer and Benign Nodules Using Routine Clinical and Laboratory Data
Wei Wei, Yun Wang, Renren Ouyang, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 12, pp. 7738-7749
Closed Access | Times Cited: 4
Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer
Shiv Verma, Diya Swain, Prem Prakash Kushwaha, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 246-246
Open Access | Times Cited: 2
Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer
Adviti Naik, Boucif Lattab, Hanan Qasem, et al.
Deleted Journal (2024) Vol. 32, Iss. 1, pp. 200768-200768
Open Access | Times Cited: 2
An Engineered M13 Filamentous Nanoparticle as an Antigen Carrier for a Malignant Melanoma Immunotherapeutic Strategy
Nuša Brišar, Katja Šuster, Simona Kranjc, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 232-232
Open Access | Times Cited: 2
The dawn of a new Era: mRNA vaccines in colorectal cancer immunotherapy
Jingjing Song, Yujun Zhang, Chulin Zhou, et al.
International Immunopharmacology (2024) Vol. 132, pp. 112037-112037
Closed Access | Times Cited: 2
Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: Delivery strategies and clinical trials
Rama Rao Malla, Mundla Srilatha, Veda Muppala, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 707-720
Closed Access | Times Cited: 2
Fusion of NY-ESO-1 epitope with heat shock protein 70 enhances its induced immune responses and antitumor activity against glioma in vitro
Yuqing Chen, Lin Zheng, Wenxi Hua, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 1, pp. 191-201
Open Access | Times Cited: 1
The use of xenogenic testicular antigens for induction of antitumor reactions
Г. В. Селедцова, A. B. Dorzhieva, I. P. Ivanova, et al.
Siberian Journal of Oncology (2024) Vol. 22, Iss. 6, pp. 111-120
Open Access
Proteomic Profiling of Pre- and Post-Surgery Saliva of Glioblastoma Patients: A Pilot Investigation
Alexandra Muntiu, Fabiana Moresi, Federica Vincenzoni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12984-12984
Open Access
Prediction and identification of HLA-A*0201-restricted epitopes from cancer testis antigen CT23
Xia Zeng, Weixia Nong, Xiaoqiong Zou, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access
Page 1

Scroll to top